Recs

5
Player Avatar DarthMaul09 (29.78) Submitted: 10/16/2009 12:58:56 AM : Underperform Start Price: $15.50 CVM Score: +186.75

Purely speculative bet that the 25% increase in stock price today was a bit excessive, although it was no were near the pop in had in August. I'm just a little pessimistic that the company can deliver a product worthy of the stock gain.

Report this Post 3 Replies
Member Avatar flatky02 (< 20) Submitted: 10/17/2009 2:40:12 PM
Recs: 0

Lol... i wouldn't say the gain was excessive... it was all those who sold off a good portion of their shares in the previous week (due to the sabatoge of wreckless journalism to wipe out the little men) and wanted to get back in before this weekends big conference. Do your homework... your pick will lose you points.

Member Avatar naughtyguy (33.06) Submitted: 9/21/2010 1:09:33 PM
Recs: 0

DarthMaul is up 62.84 points on this stock pick. LMFAO @ flatky02's post! (What homework?)

Member Avatar Iknowinvesting (< 20) Submitted: 2/18/2011 5:16:21 AM
Recs: 0

CEL-SCI Corporation (CVM) was established over 28 years ago and has been a pioneer in the development of novel therapy to head and neck cancer. By focusing on head and neck concer, CEL-SCI has made significant progress in the development of Multikine for cancer therapy. As of now, Multikine offers a unique and unparalleled approach for head and neck cancer tratement. In this report, we analyze CEL-SCI’s structure, personnel profile, scientific technology, and financials with an emphasis on current competitive pressure and future operational activity. A SWOT analysis of Human Genome Sciences is included at the end of this report to provide current and future investors with knowledge on the company’s past, current and future operations.

I bought this Report (the full one) @ www.BiotechExplorers.com, it gave me a lot of useful information about CVM.

Featured Broker Partners


Advertisement